Demirtaş Abdullah, Sabur Volkan, Akınsal Emre Can, Demirci Deniz, Ekmekcioglu Oguz, Gulmez Ibrahim, Tatlisen Atila
Department of Urology, Erciyes University Medical Faculty, 38039 Kayseri, Turkey.
ScientificWorldJournal. 2013 Mar 31;2013:703579. doi: 10.1155/2013/703579. Print 2013.
To assessment the role of preoperative neutrophil-lymphocyte ratio and postoperative lymph node density in predicting prognosis in patients undergoing radical cystectomy for bladder cancer.
Preoperatively, neutrophil and lymphocyte counts as well as neutrophil-lymphocyte ratios were recorded in 201 patients who underwent radical cystectomy for bladder cancer. Patients with an infection were excluded. Based on the pathology reports, the number of positive lymph nodes was divided by the total number of lymph nodes to calculate lymph node density.
The mean follow-up duration was 37.22 ± 35.922 months in patients without lymph node involvement and 27.75 ± 31.501 months in those with lymph node involvement (P = 0.015). Median lymph node density was 17% (4-80) in patients with lymph node involvement. There was no difference according to lymph node density lower than 17% and greater than 17% (P = 0.336). There was no significant difference between patients with an NLR below or above 2.5 in terms of overall survival (P = 0.702). Pathological T stage was associated with survival (P = 0.004).
In patients undergoing RC for bladder cancer, lymph node density and preoperative NLR were not found to be independent predictors of prognosis.
评估术前中性粒细胞与淋巴细胞比值及术后淋巴结密度在预测膀胱癌根治性膀胱切除患者预后中的作用。
术前,记录201例行膀胱癌根治性膀胱切除患者的中性粒细胞和淋巴细胞计数以及中性粒细胞与淋巴细胞比值。排除有感染的患者。根据病理报告,将阳性淋巴结数量除以淋巴结总数以计算淋巴结密度。
无淋巴结转移患者的平均随访时间为37.22±35.922个月,有淋巴结转移患者为27.75±31.501个月(P = 0.015)。有淋巴结转移患者的中位淋巴结密度为17%(4 - 80)。淋巴结密度低于17%和高于17%的患者之间无差异(P = 0.336)。NLR低于或高于2.5的患者在总生存期方面无显著差异(P = 0.702)。病理T分期与生存率相关(P = 0.004)。
在接受膀胱癌根治性膀胱切除术的患者中,未发现淋巴结密度和术前NLR是预后的独立预测因素。